A detailed history of Fusion Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Fusion Capital, LLC holds 23,022 shares of AMGN stock, worth $6.51 Million. This represents 3.31% of its overall portfolio holdings.

Number of Shares
23,022
Previous 22,937 0.37%
Holding current value
$6.51 Million
Previous $7.17 Million 3.5%
% of portfolio
3.31%
Previous 3.27%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $26,297 - $28,677
85 Added 0.37%
23,022 $7.42 Million
Q2 2024

Aug 06, 2024

SELL
$262.75 - $319.31 $92,488 - $112,397
-352 Reduced 1.51%
22,937 $7.17 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $159,171 - $192,139
592 Added 2.61%
23,289 $6.62 Million
Q4 2023

Jan 22, 2024

BUY
$255.7 - $288.46 $73,897 - $83,364
289 Added 1.29%
22,697 $6.54 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $345,685 - $429,178
1,581 Added 7.59%
22,408 $6.02 Million
Q2 2023

Aug 02, 2023

BUY
$214.27 - $253.37 $73,066 - $86,399
341 Added 1.66%
20,827 $4.62 Million
Q1 2023

May 10, 2023

BUY
$225.79 - $275.2 $5,418 - $6,604
24 Added 0.12%
20,486 $4.95 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $78,786 - $100,107
344 Added 1.71%
20,462 $5.37 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $40,178 - $45,313
179 Added 0.9%
20,118 $4.54 Million
Q2 2022

Jul 13, 2022

BUY
$230.71 - $256.74 $133,119 - $148,138
577 Added 2.98%
19,939 $4.85 Million
Q1 2022

May 03, 2022

BUY
$219.27 - $242.57 $273,648 - $302,727
1,248 Added 6.89%
19,362 $4.68 Million
Q4 2021

Jan 12, 2022

BUY
$198.88 - $227.6 $515,894 - $590,394
2,594 Added 16.71%
18,114 $4.08 Million
Q3 2021

Nov 10, 2021

BUY
$212.27 - $248.7 $338,358 - $396,427
1,594 Added 11.45%
15,520 $3.3 Million
Q2 2021

Aug 10, 2021

BUY
$233.58 - $259.14 $175,185 - $194,355
750 Added 5.69%
13,926 $3.39 Million
Q1 2021

May 17, 2021

BUY
$221.91 - $258.6 $147,348 - $171,710
664 Added 5.31%
13,176 $3.28 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $249,486 - $297,093
1,153 Added 10.15%
12,512 $2.88 Million
Q3 2020

Nov 06, 2020

SELL
$234.65 - $260.95 $11,028 - $12,264
-47 Reduced 0.41%
11,359 $2.89 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $50,243 - $61,655
254 Added 2.28%
11,406 $2.69 Million
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $79,092 - $104,897
-434 Reduced 3.75%
11,152 $2.26 Million
Q4 2019

Feb 24, 2020

BUY
$189.21 - $243.2 $2.19 Million - $2.82 Million
11,586 New
11,586 $2.79 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $151B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fusion Capital, LLC Portfolio

Follow Fusion Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fusion Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fusion Capital, LLC with notifications on news.